ROBERTS 063 (Agrylin 0.5 mg)

Generic Name: anagrelide

Pill imprint ROBERTS 063 has been identified as Agrylin 0.5 mg.

Agrylin is used in the treatment of thrombocythemia; chronic myelogenous leukemia and belongs to the drug class miscellaneous uncategorized agents. Risk cannot be ruled out during pregnancy. Agrylin 0.5 mg is not a controlled substance under the Controlled Substance Act (CSA).

Agrylin

Generic Name:

anagrelide

Imprint:

ROBERTS 063

Strength:

0.5 mg

Color:

White

Shape:

Capsule-shape

Availability:

Prescription only

Drug Class:

Miscellaneous uncategorized agents

Pregnancy Category:

C - Risk cannot be ruled out

CSA Schedule:

Not a controlled drug

Manufacturer:

Shire US Inc

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.